Hi [[ session.user.profile.firstName ]]

NIHR Clinical Research Network

  • Date
  • Rating
  • Views
  • Biosimilars - A Network perspective
    Biosimilars - A Network perspective
    Divya Chadha Manek Recorded: Mar 29 2017 15 mins
    A biosimilar medicine is a biological medicine which is highly similar to another biological medicine already licensed for use. It is a biological medicine which has been shown not to have any clinically meaningful differences from the originator biological medicine in terms of quality, safety and efficacy.
  • NIHR Clinical Research Network support for Biosimilars clinical trials
    NIHR Clinical Research Network support for Biosimilars clinical trials
    Dr Sonya Abraham, Consultant Research Physician and Rheumatologist Recorded: Mar 29 2017 16 mins
    This presentation will discuss NIHR Clinical Research Network support for Biosimilar clinical trials. It begins with a background to biosimilars and the changing landscape in their drug development and regulatory pathways. It then focuses on the opportunities that the NHS via the NIHR CRNs can engage in biosimilar clinical trials across therapeutic indications.
  • NIHR CRN processes for HRA Approval
    NIHR CRN processes for HRA Approval
    Laura Bousfield - Study Start-Up Manager | CRN National Coordinating Centre Recorded: Mar 23 2016 15 mins
    This webinar explains the role of the CRN in supporting sponsors and sites when setting up HRA Approval studies
  • NIHR Metrics (post HRA Approval)
    NIHR Metrics (post HRA Approval)
    Laura Bousfield Study Start-Up Manager | CRN National Coordinating Centre (CRNCC) | NIHR Clinical Research Network (CRN) Recorded: Mar 23 2016 15 mins
    A webinar that provides an overview of NIHR metrics, what they are and how they are calculated.
  • HRA Approval - collaboration between sponsors and sites
    HRA Approval - collaboration between sponsors and sites
    Dr Janet Messer | Director of Research Systems, Standards & HRA Approval Programme Recorded: Mar 17 2016 34 mins
    This webinar explains how sponsors and sites need to work together when setting up HRA Approval studies
  • HRA Approval - what it means for the NIHR CRN Coordinating Centre
    HRA Approval - what it means for the NIHR CRN Coordinating Centre
    Dr Janet Messer, HRA Approval Programme Director and Roz Sorrie, NIHR CRN HRA Approval Business Lead Recorded: Mar 17 2016 54 mins
    This webinar is designed for NIHR CRN Coordinating Centre staff. Find out more about HRA Approval and what it means to the NIHR CRN Coordinating Centre
  • HRA Approval - what is it and how do I apply?
    HRA Approval - what is it and how do I apply?
    Dr Janet Messer | Director of Research Systems, Standards & HRA Approval Programme Recorded: Mar 17 2016 49 mins
    This webinar will explain what HRA Approval is and how to apply for HRA Approval using IRAS
  • Health Research Authority (HRA) Approval - what it means for research in the NHS
    Health Research Authority (HRA) Approval - what it means for research in the NHS
    NIHR CRN Research Delivery Director Dr Clare Morgan and HRA Chief Executive Janet Wisely Recorded: Mar 15 2016 60 mins
    This webinar is designed for the NHS research community. Join NIHR Clinical Research Network Research Delivery Director Dr Clare Morgan and HRA Chief Executive Janet Wisely, to explore the new HRA Approval process, its implementation and how the organisations are working together to improve the clinical research environment.
  • The truth about delivering clinical research in the UK?
    The truth about delivering clinical research in the UK?
    Dr Matt Cooper, Business Development and Marketing Director Recorded: Mar 2 2016 34 mins
    •Are you looking to deliver your research within Europe?
    •Do you need multiple, reliable sites and experienced investigators?
    •Do you want to know why you should come to the UK?

    In the past the UK’s reputation for delivering clinical research was questionable. But that has all changed with the Department of Health’s investment in the clinical research network infrastructure in the UK.

    Over the last seven years the research landscape in the UK has improved dramatically allowing the UK to make great strides in delivering research for the Life Sciences industry. So whether you are a Pharmaceutical Company, Contract Research Organisation, Biotech, Med Tech or Diagnostic company we can help.

    The NIHR Clinical Research Network is hosting a live webinar which will explode common myths around the UK’s ability to deliver commercial clinical research. This session will be hosted by Dr Matt Cooper, Business Development and Marketing Director, of the National Institute for Health Research Clinical Research Network (NIHR CRN). It will include performance data that will demonstrate why the UK should be your first choice for running clinical research studies.

    You can discover:
    •How much the UK’s market volume of commercial contract research has grown and how we recruited over 34,000 patients to commercial clinical trials in 2014/15
    •What percentage of the UK’s National Health Service (NHS) is actively delivering commercial contract research studies (with support from the NIHR CRN)
    •The free feasibility service run by the NIHR CRN
    •How to gain access to our experienced clinical experts
    •How we are keeping clinical research in the public eye
    •How the UK is sharpening its competitive edge by achieving more key first global patients

    The NIHR CRN is exhibiting at the BioPharma Asia Convention 2016, visit stand B22 from 22-24 March to find out more about what we do to support clinical research and how we can help you deliver your studies in the UK.
  • The truth about delivering clinical research in the UK
    The truth about delivering clinical research in the UK
    Matt Cooper Business Development and Marketing Director Recorded: Jan 27 2016 39 mins
    •Are you looking to deliver your research within Europe?
    •Do you need multiple, reliable sites and experienced investigators?
    •Do you want to know why you should come to the UK?

    In the past the UK’s reputation for delivering clinical research was questionable. But that has all changed. Over the last seven years the research landscape in the UK has improved dramatically allowing the UK to make great strides in delivering research for the Life Sciences industry. So whether you are a Pharmaceutical company, Contract Research Organisation, Biotech, Med Tech or Diagnostic we can help.

    The NIHR Clinical Research Network is hosting a live webinar which will explode common myths around the UK’s ability to deliver commercial clinical research. This session will be hosted by Matt Cooper, Business Development and Marketing Director, of the National Institute for Health Research Clinical Research Network (NIHR CRN). It will include performance data that will demonstrate why the UK should be your first choice for clinical research. You can discover:
    •How much the UK’s market volume of commercial contract research (supported by the NIHR CRN) has changed and how we recruited more than 34,000 patients to commercial clinical trials in 2014/15
    •What percentage of the UK’s National Health Service (NHS) is actively delivering commercial contract research studies (with support from the NIHR CRN)
    •The free feasibility service run by the Network
    •How to gain access to clinical experts
    •What percentage of commercial contract studies (supported by the NIHR CRN) are delivered to time and target
    •How we are keeping clinical research in the public eye
    •How the UK is sharpening its competitive edge by achieving more and more key first global patient milestones

Embed in website or blog